静脉内热消融术后再通
该回顾性病历审查分析了2012至2015年间485例患者共1475次热消融(RFA 1027例,EVLA 448例),随访平均13.5±12个月。大隐静脉和小隐静脉再通率低,而穿通静脉和副大隐静脉再通率较高;RFA与EVLA再通率无显著差异;再通静脉再次手术成功率为76.5%。
要点
- 大隐静脉和小隐静脉热消融后再通率低;穿通静脉和副大隐静脉再通率较高。
- RFA与EVLA在再通率上无显著差异(排除穿通静脉后)。
- 再通静脉再次手术有效,成功率76.5%。
核心结论
- 大隐静脉和小隐静脉热消融后再通率低,但副大隐静脉再通率约为大隐静脉和小隐静脉的两倍,穿通静脉再通率约为五倍;RFA与EVLA再通率无显著差异;再通静脉再次手术成功率为76.5%。
研究设计与样本
- 回顾性病历审查,纳入2012至2015年间485例患者共1475次热消融,其中RFA 1027例,EVLA 448例。
主要发现
- 术后1周女性再通率2.6%,高于男性(P=0.018)。
- 大隐静脉和小隐静脉闭塞失败率均为0.8%(P=0.98);穿通静脉失败率最高为16.6%,副大隐静脉为2.9%(P<0.001)。
- 平均随访13.5±12个月,穿通静脉再通率41.2%、副大隐静脉14.85%,高于大隐静脉7.7%和小隐静脉8.5%(P<0.001)。
- 排除穿通静脉后,RFA再通率10%与EVLA 8.8%在1周和1年随访时无显著差异(P=0.54)。
- 再通患者中56%有症状;1475次手术中76次因复发症状再次手术;1年时非重复手术闭塞率86.9%高于重复手术76.3%(P=0.014)。
关键数值与推荐
- 复发定义为大隐静脉、小隐静脉和副大隐静脉>500 ms,穿通静脉>350 ms。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovenous thermal ablation in the form of radiofrequency ablation (RFA) or endovenous laser ablation (EVLA) has quickly ascended to a prime position in the treatment of venous insufficiency. Although there are good data examining the rates of thrombotic complications, there is a relative paucity of data examining the recanalization rates after endovenous thermal ablation (ETA). METHODS: Data analysis was performed for 1475 thermal ablations in 485 patients from 2012 to 2015 as a retrospective chart review. RFA was performed in 1027 patients and EVLA in 448 patients. The target veins included the great saphenous vein (GSV) (778), short saphenous vein (SSV) (401), accessory saphenous vein (ASV) (140), and perforator veins (PV) (156). Data were collected from follow-up visit within 1 week of procedure, every 3 months for the first year, and every 6 months thereafter. Recurrence was defined as >500 ms for the GSV, SSV, and ASV and as >350 ms for the PV. Data for recanalization were also correlated with age, gender, laterality, presenting symptoms, and treated targeted vein. RESULTS: The average age of the study population was 64.7 years (SD ± 15.6) with 66% women and 326 bilateral veins. At 1-week follow-up, women (2.6%) had higher recanalization rate (P = 0.018). Failure rate of obliteration for GSV and SSV were 0.8% and 0.8%, respectively (P = 0.98). PV had the highest failure rate (16.6%), followed by ASV (2.9%) (P < 0.001). At mean follow-up after 13.5 ± 12 months, PV (41.2%) and ASV (14.85) had higher recanalization rate than GSV (7.7%) and SSV (8.5%) (P < 0.001). Excluding PVs, no difference with recurrence rates between RFA (10%) and EVLA (8.8%) was observed at 1-week and 1-year follow-ups (P = 0.54). Also, 56% of patients with recanalization were symptomatic. Among these 1475 procedures, redo for recurrent symptoms were performed in 76. At 1 week, there was no difference between nonrepeated (92.7%) and repeated procedures (89.5%) (P = 0.41). However, 1 year later, there was significant difference between obliteration rate in nonrepeated (86.9%) and repeated (76.3%) procedures (P = 0.014). CONCLUSIONS: These data do suggest low overall rates of recanalization after thermal ablation of the GSV and SSV. However, at 1-year follow-up, accessory veins had almost twice the recurrence rate as compared with GSV and SSV, and PV had almost 5 times the recurrence rate. There was no significant difference between RFA and EVLA in recanalization rates. Redo procedures in recanalized veins after venous ablation are effective with a success rate at 76.5%.
引用
- Aurshina A, Alsheekh A, Kibrik P, et al. Recanalization After Endovenous Thermal Ablation. Ann Vasc Surg. 2018. PMID: 29777845. doi:10.1016/j.avsg.2018.03.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。